The Oregon Clinical & Translational Research Institute (OCTRI) has funded four projects designed to enhance translational research at OHSU. These novel, collaborative, multidisciplinary studies will lead to further research and funding in translational research. The funding was made available through institutional support of OCTRI from the School of Medicine (Research Roadmap initiative) and the Office of the Senior Vice President for Research.
Congratulations to the 2015 Catalyst Award winners:
“Bromodomain Inhibition For The Treatment Of Lethal Prostate Cancer”
“Reproductive Health of Women with Disabilities Initiative”
Stephen Lloyd, Ph.D.
“DNA Glycosylases: Novel Targets for Small Molecule-induced Synthetic Lethality”
William Messer, M.D., Ph.D.
“Long-term DENV immunity in a human cohort”
OCTRI Catalyst funding is specifically intended to enable the development of compelling new grant applications that will sustain the proposed research activity. Please see the OCTRI Funding Opportunities page for more information or contact Colleen Lay.